Proteomic Characterization of Cytoskeletal and Mitochondrial Class III -Tubulin

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Proteomic and Immunohistological Characterization of Cytoskeletal Alterations During the Progression of Human Cardiomyopathy

Biophysical Journal
Biophysics
2017English

Class III Β-Tubulin Is a Component of the Mitotic Spindle in Multiple Cell Types

Journal of Histochemistry and Cytochemistry
AnatomyHistology
2008English

Class III -Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2007English

Phenotypic Characterization of New Mouse Model of Class III Malocclusion

Egyptian Orthodontic Journal
2013English

Overexpression of Class III Β-Tubulin, Sox2, and Nuclear Survivin Is Predictive of Taxane Resistance in Patients With Stage III Ovarian Epithelial Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

The Tubulin Cofactor C Family Member TBCCD1 Orchestrates Cytoskeletal Filament Formation

Journal of Cell Science
Cell Biology
2013English

Biochemical and Proteomic Characterization of Alkaptonuric Chondrocytes

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2012English

Proteomic Characterization of the Cytotoxic Mechanism of Gold (III) Porphyrin 1a, a Potential Anticancer Drug

Proteomics
BiochemistryMolecular Biology
2006English

Clinical Significance of Class III Β-Tubulin Expression and Its Predictive Value for Resistance to Docetaxel-Based Chemotherapy in Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy